Where is your factory located?

Our company is located in Hangzhou, Zhejiang, China.

What are the payment terms?

We accept LC, T/T, and D/P as payment terms.

What is your production capacity for antigens?

Our production capacity for recombinant antigens is 18g per month.

Testsealabs Canine Giardia Antigen Test Diagnostic Kits OEM Cheap One Step

Name: Testsealabs Canine Giardia Antigen Test Diagnostic Kits OEM Cheap One Step
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 1994853415

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$2.50

1,000 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Certificate

ISO9001, ISO13485, CE

Model NO.

Test Kits

Shelf life

2 Years

OEM/ODM

Support

Samples

Support

Transport Package

Carton

Specification

20tests/box

Trademark

TESTSEALABS

Origin

China

HS Code

3005109000

Production Capacity

100000000

Key features

OEM/ODM Support: Full OEM and ODM services available for customized diagnostic kits.

ISO Certifications: Certified under ISO9001 and ISO13485 for quality management.

Long Shelf Life: Product shelf life is guaranteed for 2 years.

Sample Availability: Samples are available for testing and evaluation.

Advanced R&D Team: Led by doctors and masters with 9 dedicated R&D engineers.

High Production Capacity: Recombinant antigen production capacity reaches 18g per month.

GMP Workshop: Features 2,000 square meters of 100,000-level purification workshop.

Global Market Reach: Products exported to North America, Europe, Asia, Africa, and Latin America.

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤11.16h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology is identified as a China-based limited company in Hangzhou, with records describing it as both a trading company and manufacturer/factory. Its stated capabilities include in-vitro diagnostic, veterinary, rapid-test, reagent, and medical-machine products. The supplier reports ISO 9001 and GMP certification, more than 10 production lines, 50 R&D engineers, 50 quality-control staff, and exports to multiple global regions. It describes three technical platforms and sales coverage exceeding 100 countries and regions. However, the evidence does not establish after-sales performance, financial credibility, or product-customization capability. One record associates the supplier with a 2025 THC urine-test product and a Vietnamese buyer, but this is limited customer evidence and does not independently verify broader performance.

Supplier typeThe supplier is identified as a limited company headquartered in Hangzhou, China, and is described as both a trading company/manufacturer-factory. A separate record characterizes the company nature as a factory, supporting a manufacturing role alongside trading activity.

CertificationsThe supplier reports ISO 9001 and GMP certification under its management-system certifications. These are explicit certifications relevant to quality and manufacturing controls.

R&D capabilityThe supplier states that it develops core innovative raw-material technologies and has established immunological detection, molecular-biology detection, and protein core-sheet inspection platforms. The reported 50 R&D engineers and continuing R&D investment further support an established innovation function.

Production capacityThe supplier reports more than 10 production lines, 50 quality-control staff, a one-month off-peak lead time, and broad diagnostic-product offerings. It also reports 90% export sales and access to Shanghai, Ningbo, and Shenzhen ports, although the stated peak-season fulfillment time of 6–12 months indicates substantial seasonal capacity constraints.

Client casesThe supplier states that its products have been sold in more than 100 countries and regions. A separate record identifies a THC urine-test product and one associated Vietnamese buyer, but it does not provide verifiable case details such as order scale, duration, performance results, or references.